A Novel Strategy for the
Management of Inpatient Hyperglycemia in Patients with Type 2 Diabetes
Free to AADE
Annual Meeting Symposium, 60 minutes
Effective dates for CE credit: 8/5/2017 – 8/5/2019
1.0 CE credits
This presentation shares strategies for managing inpatient
hyperglycemia in patients with type 2 diabetes and outlines the impact on
clinical outcomes. We also review strategies for starting and stopping diabetes
medications in patients undergoing surgery and discuss the role of DPP-4
inhibitors for the treatment of inpatient hyperglycemia in type 2 diabetes
This recording of a live presentation is a knowledge-based learning
At the end of this presentation, the participant will be able to:
- Outline current recommendations
for the treatment of hyperglycemia in patients hospitalized with type 2
- Discuss the appropriate times to stop and start diabetes meds for patients
- Assess the effect of hypoglycemia on clinical outcomes and the importance of
avoiding it in hospitalized patients with type 2 diabetes
- Review the rationale and current data for the use of with insulin and non-insulin
agents in hospitalized patients with type 2 diabetes
This is a knowledge-based activity designed for individual or groups
of diabetes educators, including RNs, RDs, Pharmacists, Nurse Practitioners,
Clinical Nurse Specialists, Physician Assistants, MDs, and other health care
providers interested in staying up to date on current practices of care for
their patients with diabetes and other related conditions.
Guillermo E. Umpierrez, MD, CDE, FACE, FACP
Professor of Medicine
Director, Clinical Research, Diabetes and Metabolism Center
Emory University School of Medicine
Director, Diabetes & Endocrinology Section
Grady Health System
This program is supported by an independent medical educational grant
from Merck, Inc..
Continuing Education Credit
This educational program will provide 1.0 contact hours of continuing
education credit. To successfully complete the program to earn CE credit,
learners must view the recorded session in its entirety, successfully complete
a short post-learning assessment, and submit an evaluation survey. A continuing
education statement of credit will be provided online.
American Association of Diabetes Educators is accredited as a provider of
continuing nursing education by the American Nurses Credentialing Center's
Commission on Accreditation.
educational program will provide 1.0 contact hours of continuing education
is accredited as a provider of continuing nursing education by the California
Board of Registered Nursing (CEP # 10977).
American Association of Diabetes Educators, (AM001) is a Continuing
Professional Education (CPE) Accredited Provider with the Commission on
Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic
technicians, registered (DTRs) will receive 1.0 continuing professional
education units (CPEUs) for completion of this program. Continuing Professional
Education Provider Accreditation does not constitute endorsement by CDR of a
provider, program, or materials.
American Association of Diabetes Educators is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy
education. This program provides 1.0 contact hours (0.10 CEUs) of
continuing education credit.
Universal Program Number: 0069-0000-17-241-H01-P
Dates: 8/5/2017 – 8/5/2019
It is the policy of the American Association of Diabetes Educators to
require that anyone who has an opportunity to affect continuing education activities
content (e.g. authors, presenters and program planners) with products or
services from a commercial interest with which s/he has financial
relationships, discloses those financial relationship/s with commercial
entities to participants.
Disclosure of a relationship is not intended to suggest or condone bias in any
presentation, but is made to provide participants with information that might
be of potential importance to their evaluation of a presentation.
Relevant disclosures (or lack thereof) among educational activity faculty and
planners are as follows.
- Dr. Umpierrez makes the following disclosures: BMJ Open Diabetes Research and
Care—Editor in Chief; Endocrine Society—Council at Large; AACE—Board of
Directors; Industry funds to Emory University for investigator-initiated
research projects: Merck, Sanofi, Novo Nordisk, Boehringer Ingelheim, Astra
- Brian Lee states that he has no relevant financial relationships to disclose.
- Elizabeth Wilkerson states that she has no relevant financial relationships
- Katie Oakes states that she has no relevant financial relationships to
- Leslie E. Kolb, MBA, BSN, RN, AADE, Chicago, IL, states that she has no
relevant financial relationships to disclose.
The approval of this educational offering by the AADE does not imply
endorsement of specific therapies, treatments, or products discussed in the
presentations. Any discussion of off-label use or investigational information
is disclosed to the learners during the presentation.
Originally presented on: 8/5/2017
Expiration date: 8/5/2019
You will have access to this learning activity for a period of six
months after you enroll, or whenever the activity's CE credits expire
(whichever comes first).
Volume discounts are available and will be automatically applied at check-out
when the desired quantity is selected
-- Groups of 4-9: 10% off
-- Groups of 10-19: 20% off
-- Groups of 20-29: 30% off
-- Groups of 30+ and Members: Contact firstname.lastname@example.org
to get a custom quote.
AADE CB's and LNG's: Please contact us at email@example.com
to order a recorded webinar for a group viewing.